IL-2 low dose and treatment interruption: interview with Kendall A. Smith. Interview by John S. James.
Smith
K A
KA
D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007279:Injections, Subcutaneous; D007376:Interleukin-2 / Q000008:administration & dosage*
D007376:Interleukin-2